Ann: Appendix 4E and Preliminary Final Report, page-4

In other words.
Any income derived from nanoparticle sales will be soaked up by employee costs.
They are hoping to receive some cost relief through R & D income tax incentives just like they received in 2023 so they can pay staff their fully entitled severance numeration b4 they fold.
Unfortunately, with no research and development trials scheduled for this year, because the company is broke, there cannot be any further Gov R&D tax incentives for 2024.
So the company is happy to milk all dwindling available cash incoming to pay themselves b4 winding up.